245 related articles for article (PubMed ID: 25078885)
61. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
62. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.
Dossenbach-Glaninger A; van Trotsenburg M; Dossenbach M; Oberkanins C; Moritz A; Krugluger W; Huber J; Hopmeier P
Clin Chem; 2003 Jul; 49(7):1081-6. PubMed ID: 12816904
[TBL] [Abstract][Full Text] [Related]
63. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
[TBL] [Abstract][Full Text] [Related]
64. The presence of PAI-1 4G/5G and ACE DD genotypes increases the risk of early-stage AVF thrombosis in hemodialysis patients.
Güngör Y; Kayataş M; Yıldız G; Özdemir Ö; Candan F
Ren Fail; 2011; 33(2):169-75. PubMed ID: 21332339
[TBL] [Abstract][Full Text] [Related]
65. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
[TBL] [Abstract][Full Text] [Related]
66. Association of PAI-1 4G/5G and ACE I/D Polymorphisms with Susceptibility to Pediatric Sepsis: Evidence from a Meta-Analysis.
Jarahzadeh MH; Jafari M; Seifi-Shalamzari N; Ferdosian F; Bahrami R; Raee-Ezzabadi A; Nafei Z; Shajari A; Mirjalili SR; Neamatzadeh H
Fetal Pediatr Pathol; 2022 Apr; 41(2):242-258. PubMed ID: 32536239
[No Abstract] [Full Text] [Related]
67. Sequence variants of ACE, AGT, AT1R, and PAI-1 as genetic risk factors for vascular dementia.
Kim Y; Kim JH; Nam YJ; Kim YJ; Yu KH; Lee BC; Lee C
Neurosci Lett; 2006 Jul; 401(3):276-9. PubMed ID: 16603315
[TBL] [Abstract][Full Text] [Related]
68. Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.
Yioti GG; Panagiotou OA; Vartholomatos GA; Kolaitis NI; Pappa CN; Evangelou E; Stefaniotou MI
Ophthalmic Genet; 2013 Sep; 34(3):130-9. PubMed ID: 23289804
[TBL] [Abstract][Full Text] [Related]
69. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
[TBL] [Abstract][Full Text] [Related]
70. Thrombophilic gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis.
Wen Y; He H; Zhao K
J Assist Reprod Genet; 2023 Jul; 40(7):1533-1558. PubMed ID: 37248348
[TBL] [Abstract][Full Text] [Related]
71. Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease.
Loew M; Hoffmann MM; Hahmann H; Maerz W; Brenner H; Rothenbacher D
Eur J Cardiovasc Prev Rehabil; 2006 Jun; 13(3):449-56. PubMed ID: 16926677
[TBL] [Abstract][Full Text] [Related]
72. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
Gong LL; Peng JH; Han FF; Zhu J; Fang LH; Wang YH; Du GH; Wang HY; Liu LH
Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216
[TBL] [Abstract][Full Text] [Related]
73. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
[TBL] [Abstract][Full Text] [Related]
74. [PAL-1 5G/4G polymorphism in patients with systemic lupus erythematosus].
Savov A; Andonova S; Tanev D; Robeva R; Marincheva Ts; Tomova A; Kumanov P; Rashkov R; Kolarov Z
Akush Ginekol (Sofiia); 2014; 53(7):13-7. PubMed ID: 25675617
[TBL] [Abstract][Full Text] [Related]
75. Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with Recurrent Pregnancy Loss: a Meta-Analysis of 26 Case-Control Studies.
Aslbahar F; Neamatzadeh H; Tabatabaiee RS; Karimi-Zarchi M; Javaheri A; Mazaheri M; Foroughi E; Nasiri R
Rev Bras Ginecol Obstet; 2018 Oct; 40(10):631-641. PubMed ID: 30352462
[TBL] [Abstract][Full Text] [Related]
76. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
Incalcaterra E; Meli F; Muratori I; Corrado E; Amato C; Canino B; Ferrara F
Thromb Res; 2014 Mar; 133(3):371-4. PubMed ID: 24485402
[TBL] [Abstract][Full Text] [Related]
77. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.
Su CK; Yeh KT; Yeh CB; Wang PH; Ho ES; Chou MC; Liu KC; Yang SF; Yi YC
J Surg Oncol; 2011 Dec; 104(7):755-9. PubMed ID: 21761413
[TBL] [Abstract][Full Text] [Related]
78. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
[TBL] [Abstract][Full Text] [Related]
79. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
[TBL] [Abstract][Full Text] [Related]
80. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
Eroglu A; Ulu A; Cam R; Akar N
J BUON; 2006; 11(4):481-4. PubMed ID: 17309181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
